Skip to main content
  • Home
  • About Us
  • Advisory Board
  • Advertise
  • Editorial Submissions
  • Contact Us
  • Subscribe to Newsletter

  • Follow me on Twitter
  • Friend me on Facebook
  • Connect with me on LinkedIn
  • Subscribe to me on YouTube
  • Subscribe to my RSS Feed

Menu

Skip to content
  • MedTech Economics
  • Policy
  • Manufacturing Execution
  • Product Design & Development
  • Quality & Compliance
  • Digital Health
  • Resource Library
  • Events & Webinars

MedTech Economics

November 12, 2015

American Diabetes Month: Fast Stats about the Disease

By Maria Fontanazza

This month MedTech Intelligence will cover the diabetes market, along with technologies and solutions that are improving patient quality of life.

Continue reading →

Maria Fontanazza and Michael Lohan, IDA Ireland, AdvaMed 2015
November 6, 2015
Maria Fontanazza and Michael Lohan, IDA Ireland, AdvaMed 2015

Ireland Remains Competitive in Medical Device Sector

By MedTech Intelligence Staff

With an established base of medtech companies and a strong workforce, Ireland remains a key player in the global supply chain.

Continue reading →

Joan Koerber-Walker and Maria Fontanazza, economic development in medtech, AdvaMed 2015
November 5, 2015
Joan Koerber-Walker and Maria Fontanazza, economic development in medtech, AdvaMed 2015

Finding the Right Ecosystem for MedTech Innovation

By MedTech Intelligence Staff

In order to keep innovation and manufacturing in the United States, device companies need federal and local support.

Continue reading →

October 30, 2015
MEDdesign

Science Fiction Meets Nano-Robots

By Klaus Jopp

A peek at the latest miniaturization trends, including nano-robots that transport therapeutics to tumors.

Continue reading →

October 29, 2015

Digital Health Hot Topic at RAPS 2015

By Maria Fontanazza

Managing data, interoperability and cybersecurity issues were at the top of the list for industry stakeholders.

Continue reading →

Finger prick lab tests, Theranos
October 28, 2015
Finger prick lab tests, Theranos

FDA Says Theranos Device Uncleared, Finds Host of Problems

By Maria Fontanazza

Mainstream media attention catapulted the company to the center of controversy for its finger-prick lab tests. Now FDA has taken issue with the company’s complaint handling and design validation.

Continue reading →

Maria Fontanazza and Ian Strickland discuss future of medtech market at AdvaMed 2015
October 15, 2015
Maria Fontanazza and Ian Strickland discuss future of medtech market at AdvaMed 2015

MedTech Market to Hit $470 Billion by 2020, Prepare for Consolidation

By MedTech Intelligence Staff

Expect to see slow growth and more mergers & acquisitions.

Continue reading →

John Babitt, Ernst & Young, Pulse of the Industry report at AdvaMed 2015
October 14, 2015
John Babitt, Ernst & Young, Pulse of the Industry report at AdvaMed 2015

2015 MedTech Highlights: Low Industry Growth, VC Declines, M&A Impressive

By MedTech Intelligence Staff

Ernst & Young’s Pulse of the Industry report is out, and once again, it’s not all gloom and doom.

Continue reading →

Pediatric technologies
October 8, 2015
Pediatric technologies

MedTech Designers: Children Are Not Small Adults

By Maria Fontanazza

There is a great unmet need for pediatric-specific devices. Why aren’t more manufacturers addressing this critical area?

Continue reading →

MobileODT, Clinician uses device
October 1, 2015
MobileODT, Clinician uses device

Mobile Technology Ready to Change Standard of Care in Cervical Cancer Detection

By Maria Fontanazza

The technology platform has already gone global and has the potential to be a true breakthrough in screening and detecting several types of cancer.

Continue reading →

Post navigation

  • Previous
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • Next

Upcoming Events & Webinars

No posts found.



On Demand Events & Webinars

No posts found.






Columns

April 20, 2026

Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition

By MedTech Intelligence Staff
Stryker

Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

April 17, 2026

The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators

By Melissa Corneal

Traditionally, contract negotiation has been viewed as a financial or legal responsibility, typically led by finance teams, legal counsel, or executive leadership, with operations stepping in afterward to execute against decisions that have already been made, but that model is evolving as healthcare delivery becomes more interconnected and operationally complex, requiring administrators to engage earlier in the process, not only to understand what is being agreed to but to help define how those agreements will function in real-world environments.

March 27, 2026

Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows

By MedTech Intelligence Staff

What we’re reading on LinkedIn… Review of leading healthcare AI reports illustrate several conditions creating fertile ground for applied AI in healthcare operations.

March 20, 2026

Mindray North America Enters Ventilator Market

By MedTech Intelligence Staff

Mindray says its entry into the ventilator market marks a significant step in expanding advanced respiratory care options for clinicians and patients, reinforcing the medical device leader’s commitment to driving innovation in healthcare.

March 20, 2026

LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea

By MedTech Intelligence Staff

Hypoglossal nerve stimulation therapy approved in the U.S. without complete concentric collapse contraindication or warning language. The next-generation, MRI-compatible device is expected to launch in the first half of 2027, pending FDA supplement review.

March 20, 2026

EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization

By MedTech Intelligence Staff
EPA Logo

The medical device industry and EPA have been in ongoing debate over balancing the need for sterile medical equipment with concerns about pollution near sterilization plants.

March 18, 2026

Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia

Prodeon Medical

The Urocross Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is intentionally retrieved, leaving no permanent foreign material behind.

March 18, 2026

JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)

By MedTech Intelligence Staff
JenaValve

With its FDA approval, JenaValve intends to commence launch activity for the Trilogy System immediately with participating clinical study sites.

TOPICS

  • Digital Health
  • MedTech Economics
  • Manufacturing Execution
  • Product Design & Development
  • Quality/Regulatory

Upcoming Events & Webinars

No posts found.

Contact Us

  • Advertising Opportunities
  • Editorial Submissions
  • General Inquiries
  • Privacy Policy
  • Cookie Policy
  • Sign Up for Newsletters

Innovative Publishing Company, Inc.

  • FoodSafetyTech
  • Food Safety Consortium Conference & Expo
  • MedTech Intelligence
  • Cannabis Industry Journal

© Copyright 2015 - 2026 Innovative Publishing Co., Inc., All Rights Reserved

Other Innovative Publishing Co., Inc. Sites: Food Safety Tech  |  Cannabis Industry Journal

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

MedTech Intelligence
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

We use tracking pixels that set your arrival time at our website, this is used as part of our anti-spam and security measures. Disabling this tracking pixel would disable some of our security measures, and is therefore considered necessary for the safe operation of the website. This tracking pixel is cleared from your system when you delete files in your history.

We also use cookies to store your preferences regarding the setting of 3rd Party Cookies.

Cookie Policy

A browser cookie is a small piece of data that is stored on your device to help websites and mobile apps remember things about you. Other technologies, including Web storage and identifiers associated with your device, may be used for similar purposes. In this policy, we say “cookies” to discuss all of these technologies.

Our Privacy Policy explains how we collect and use information from and about you when you use This website and certain other Innovative Publishing Co LLC services. This policy explains more about how we use cookies and your related choices.

How We Use Cookies

Data generated from cookies and other behavioral tracking technology is not made available to any outside parties, and is only used in the aggregate to make editorial decisions for the websites. Most browsers are initially set up to accept cookies, but you can reset your browser to refuse all cookies or to indicate when a cookie is being sent by visiting this Cookies Policy page. If your cookies are disabled in the browser, neither the tracking cookie nor the preference cookie is set, and you are in effect opted-out.

In other cases, our advertisers request to use third-party tracking to verify our ad delivery, or to remarket their products and/or services to you on other websites. You may opt-out of these tracking pixels by adjusting the Do Not Track settings in your browser, or by visiting the Network Advertising Initiative Opt Out page.

You have control over whether, how, and when cookies and other tracking technologies are installed on your devices. Although each browser is different, most browsers enable their users to access and edit their cookie preferences in their browser settings. The rejection or disabling of some cookies may impact certain features of the site or to cause some of the website’s services not to function properly.

Individuals may opt-out of 3rd Party Cookies used on IPC websites by adjusting your cookie preferences through this Cookie Preferences tool, or by setting web browser settings to refuse cookies and similar tracking mechanisms. Please note that web browsers operate using different identifiers. As such, you must adjust your settings in each web browser and for each computer or device on which you would like to opt-out on. Further, if you simply delete your cookies, you will need to remove cookies from your device after every visit to the websites. You may download a browser plugin that will help you maintain your opt-out choices by visiting www.aboutads.info/pmc. You may block cookies entirely by disabling cookie use in your browser or by setting your browser to ask for your permission before setting a cookie. Blocking cookies entirely may cause some websites to work incorrectly or less effectively.

The use of online tracking mechanisms by third parties is subject to those third parties’ own privacy policies, and not this Policy. If you prefer to prevent third parties from setting and accessing cookies on your computer, you may set your browser to block all cookies. Additionally, you may remove yourself from the targeted advertising of companies within the Network Advertising Initiative by opting out here, or of companies participating in the Digital Advertising Alliance program by opting out here.